Publicación:
Medicina de precisión en sepsis: utilidad de los biomarcadores en pacientes biomarcadores en pacientes críticamente enfermos

Vista sencilla de ítem
dc.contributor.authorMolano Franco, Danielspa
dc.contributor.authorGómez Duque, Mariospa
dc.contributor.authorBeltrán, Edgarspa
dc.contributor.authorVillabón González, Mariospa
dc.contributor.authorRobayo Valbuena, Ivan Felipespa
dc.contributor.authorFranco, Luis Felipespa
dc.contributor.authorCárdenas Colmenares, Jorge Albertospa
dc.contributor.authorEstupiñán Monsalve, Álvarospa
dc.contributor.authorSánchez Vanegas, Guillermospa
dc.contributor.authorArévalo Rodriguez, Ingridspa
dc.contributor.authorZamora Romero, Javierspa
dc.date.accessioned2020-08-18 13:11:22
dc.date.accessioned2022-06-29T19:38:11Z
dc.date.available2020-08-18 13:11:22
dc.date.available2022-06-29T19:38:11Z
dc.date.issued2020-08-18
dc.format.mimetypeapplication/pdfspa
dc.format.mimetypetext/htmlspa
dc.format.mimetypeapplication/epub+zipspa
dc.format.mimetypetext/xmlspa
dc.format.mimetypeaudio/mpegspa
dc.identifier.doi10.31260/RepertMedCir.01217273.973
dc.identifier.eissn2462-991X
dc.identifier.issn0121-7372
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/2947
dc.identifier.urlhttps://doi.org/10.31260/RepertMedCir.01217273.973
dc.language.isospaspa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludspa
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/973/1176
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/973/1306
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/973/1305
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/973/1293
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/973/1311
dc.relation.citationeditionNúm. 2 , Año 2020 : Mayo - Agostospa
dc.relation.citationendpage83
dc.relation.citationissue2spa
dc.relation.citationstartpage75
dc.relation.citationvolume29spa
dc.relation.ispartofjournalRevista Repertorio de Medicina y Cirugíaspa
dc.relation.referencesDellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637.spa
dc.relation.referencesLevy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.spa
dc.relation.referencesSankar V, Webster NR. Clinical application of sepsis biomarkers. J Anesth. 2013;27(2):269-83.spa
dc.relation.referencesRangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273(2):117-23.spa
dc.relation.referencesSinger M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.spa
dc.relation.referencesFleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193(3):259-72.spa
dc.relation.referencesCawcutt KA, Peters SG. Severe sepsis and septic shock: clinical overview and update on management. Mayo Clin Proc. 2014;89(11):1572-8.spa
dc.relation.referencesRhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-77.spa
dc.relation.referencesWang T, Derhovanessian A, De Cruz S, Belperio JA, Deng JC, Hoo GS. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J Intensive Care Med. 2014;29(2):87-95.spa
dc.relation.referencesWhittaker SA, Fuchs BD, Gaieski DF, Christie JD, Goyal M, Meyer NJ, et al. Epidemiology and outcomes in patients with severe sepsis admitted to the hospital wards. J Crit Care. 2015;30(1):78-84.spa
dc.relation.referencesWunsch H, Guerra C, Barnato AE, Angus DC, Li G, Linde-Zwirble WT. Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA. 2010;303(9):849-56.spa
dc.relation.referencesYende S, Linde-Zwirble W, Mayr F, Weissfeld LA, Reis S, Angus DC. Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;189(9):1065-74.spa
dc.relation.referencesHarbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396-402.spa
dc.relation.referencesBone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-55.spa
dc.relation.referencesSandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014;10(10):1349-56.spa
dc.relation.referencesSeymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321(20):2003-17.spa
dc.relation.referencesRautanen A, Mills TC, Gordon AC, Hutton P, Steffens M, Nuamah R, et al. Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study. Lancet Respir Med. 2015;3(1):53-60.spa
dc.relation.referencesvan Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in Sepsis. Crit Care Clin. 2018;34(1):139-52.spa
dc.relation.referencesRello J, van Engelen TSR, Alp E, Calandra T, Cattoir V, Kern WV, et al. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2018;24(12):1264-72.spa
dc.relation.referencesKibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66 Suppl 2:ii33-40.spa
dc.relation.referencesMolano Franco D, Arevalo‐Rodriguez I, Roqué i Figuls M, Zamora J. Interleukin‐6 for diagnosis of sepsis in critically ill adult patients. The Cochrane Database of Systematic Reviews. 2015;2015(7):CD011811.spa
dc.relation.referencesOnyenekwu CP, Okwundu CI, Ochodo EA. Procalcitonin, C‐reactive protein, and presepsin for the diagnosis of sepsis in adults and children. Cochrane Database of Systematic Reviews. 2017(4) :CD012627. doi: 10.1002/14651858.CD012627.spa
dc.relation.referencesLiu Y, Hou JH, Li Q, Chen KJ, Wang SN, Wang JM. Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis. Springerplus. 2016;5(1):2091.spa
dc.relation.referencesHoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21(5):474-81.spa
dc.relation.referencesLee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract. 2013;67(12):1350-7.spa
dc.relation.referencesLiu D, Su L, Han G, Yan P, Xie L. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(6):e0129450.spa
dc.relation.referencesSchuetz P, Christ-Crain M, Müller B. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care. 2007;13(5):578-85.spa
dc.relation.referencesMartínez-Sagasti F, Velasco-López E, Domingo-Marín S, Gil-Perdomo JM. Usefulness of biomarkers on infection management: with or without them? Rev Esp Quimioter. 2018;31 Suppl 1:43-6.spa
dc.relation.referencesDebiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, et al. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med. 2014;42(12):2500-7.spa
dc.relation.referencesMasson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care. 2014;18(1):R6.spa
dc.relation.referencesHiggins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: The Cochrane Collaboration; 2011.spa
dc.relation.referencesGiannakopoulos K, Hoffmann U, Ansari U, Bertsch T, Borggrefe M, Akin I, et al. The Use of Biomarkers in Sepsis: A Systematic Review. Curr Pharm Biotechnol. 2017;18(6):499-507.spa
dc.relation.referencesWu Y, Wang F, Fan X, Bao R, Bo L, Li J, et al. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 2012;16(6):R229.spa
dc.relation.referencesKofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007;11(2):R38.spa
dc.relation.referencesRoldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 1990;9(2):467-74.spa
dc.relation.referencesWittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen SS, et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect. 2004;10(5):409-15.spa
dc.relation.referencesSavva A, Raftogiannis M, Baziaka F, Routsi C, Antonopoulou A, Koutoukas P, et al. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis. J Infect. 2011;63(5):344-50.spa
dc.relation.referencesGiamarellos-Bourboulis EJ, Norrby-Teglund A, Mylona V, Savva A, Tsangaris I, Dimopoulou I, et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care. 2012;16(4):R149.spa
dc.relation.referencesKumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-96.spa
dc.relation.referencesMolano Franco D ARI, Sanchez G, Gomez M, Villabon, M NX, Ferrer R, Beltran Linares E, Costa T, Zamora J. Sepsis biomarkers for prognosis of critically ill adult patients: a suite of prognostic factors systematic reviews. Prospero. 2019.spa
dc.relation.referencesGentile LF, Cuenca AG, Vanzant EL, Efron PA, McKinley B, Moore F, et al. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods. 2013;61(1):3-9.spa
dc.relation.referencesCabioglu N, Bilgic S, Deniz G, Aktas E, Seyhun Y, Turna A, et al. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg. 2002;137(9):1037-43; discussion 43.spa
dc.relation.referencesWunder C, Eichelbrönner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res. 2004;53(4):158-63.spa
dc.relation.referencesPallás Beneyto LA, Rodríguez Luis O, Saiz Sánchez C, Coltell O, Bautista Rentero D, Miguel Bayarri V. [Prognostic value of interleukin 6 for death of patients with sepsis]. Med Clin (Barc). 2016;147(7):281-6.spa
dc.relation.referencesTsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, et al. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med. 2012;43(1):97-106.spa
dc.relation.referencesOberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock. 2005;23(6):488-93.spa
dc.relation.referencesLarsen FF, Petersen JA. Novel biomarkers for sepsis: A narrative review. Eur J Intern Med. 2017;45:46-50.spa
dc.relation.referencesSager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15.spa
dc.relation.referencesPrado-Díaz A, Castillo A, Rojas DM, Chávez-Vivas M. Marcadores moleculares en el diagnóstico y pronóstico de sepsis, sepsis grave y choque séptico. Revista de la Facultad de Medicina.2017;65:145-55.spa
dc.relation.referencesGriselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med. 1999;190(12):1733-40.spa
dc.relation.referencesMortensen RF. C-reactive protein, inflammation, and innate immunity. Immunol Res. 2001;24(2):163-76.spa
dc.relation.referencesVolanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001;38(2-3):189-97.spa
dc.relation.referencesMorley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci. 1982;389:406-18.spa
dc.relation.referencesMacy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43(1):52-8.spa
dc.relation.referencesPepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12.spa
dc.relation.referencesPóvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11(2):101-8.spa
dc.relation.referencesBalcI C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003;7(1):85-90.spa
dc.relation.referencesCarrillo Esper R, Pérez Calatayud ÁA. Procalcitonina como marcador de procesos infecciosos en cirugía. Conceptos actuales. Cirujano general. 2013;35(1):49-55.spa
dc.relation.referencesWacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-35.spa
dc.relation.referencesVijayan AL, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.spa
dc.relation.referencesSchuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059-66.spa
dc.relation.referencesBouwmeester W, Zuithoff NP, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, et al. Reporting and methods in clinical prediction research: a systematic review. PLoS Med. 2012;9(5):1-12.spa
dc.relation.referencesPeat G, Riley RD, Croft P, Morley KI, Kyzas PA, Moons KG, et al. Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols. PLoS Med. 2014;11(7):e1001671.spa
dc.relation.referencesSaavedra Ramírez PG, Vásquez Duque GM, González Naranjo LA. Interleucina-6: ¿amiga o enemiga? Bases para comprender su utilidad como objetivo terapéutico. Iatreia; Vol 24, Núm 2. 2011.spa
dc.relation.referencesNishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nature Clinical Practice Rheumatology. 2006;2(11):619-26.spa
dc.relation.referencesKimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830-5.spa
dc.relation.referencesKishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22(5):347-52.spa
dc.relation.referencesGabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2:S3.spa
dc.relation.referencesJiang Y, Liu AH, Huang QB. p38 MAPK Signal is Necessary for TNF-alpha Gene Expression in RAW Cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 1999;31(1):9-15.spa
dc.relation.referencesZou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-9.spa
dc.relation.referencesCamargo, Rubio R FCD, Thomae R, Alcocer Olaciregui A, Vargas Moranth R. Diagnóstico y pronóstico de sepsis con presepsina en el Departamento de Urgencias. Acta Colomb Cuid Intensivo 2018;18(2):92-9.spa
dc.relation.referencesGiavarina D, Carta M. Determination of reference interval for presepsin, an early marker for sepsis. Biochem Med (Zagreb). 2015;25(1):64-8.spa
dc.relation.referencesWu J, Hu L, Zhang G, Wu F, He T. Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(7):e0133057.spa
dc.relation.referencesKanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm. 2004;13(5-6):313-9.spa
dc.relation.referencesØstervig RM, Køber L, Forberg JL, Rasmussen LS, Eugen-Olsen J, Iversen K. SuPAR - A future prognostic biomarker in emergency medicine. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2015;23(Suppl 1):A31-A.spa
dc.relation.referencesMolano Franco D AI, Sanchez G, Gomez M, Villabon M, Nubials X, Ferrer R, Beltran Linares E, Costa T, Zamora J. Sepsis biomarkers for prognosis of critically ill adult patients: a suite of prognostic factors systematic reviews. Prospero. 2019.spa
dc.rightsRevista Repertorio de Medicina y Cirugía - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/973spa
dc.subjectmedicina de precisiónspa
dc.subjectbiomarcadorspa
dc.subjectsepsisspa
dc.subjectInterleuquina 6spa
dc.subjectproteína C reactivaspa
dc.subjectprocalcitoninaspa
dc.subjectpresepsinaspa
dc.subjectdiagnósticospa
dc.subjectpronósticospa
dc.subjectPrecision medicineeng
dc.subjectbiomarkereng
dc.subjectsepsiseng
dc.subjectInterleukin-6eng
dc.subjectC-reactive proteineng
dc.subjectprocalcitonineng
dc.subjectpresepsineng
dc.subjectdiagnosiseng
dc.subjectprognosiseng
dc.titleMedicina de precisión en sepsis: utilidad de los biomarcadores en pacientes biomarcadores en pacientes críticamente enfermosspa
dc.title.translatedPrecision medicine in sepsis: usefulness of biomarkers In critically ill patientsbiomarkers In critically ill patienteng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREVspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Colecciones

BA. Revista Repertorio